RxDoctor Payments Data

Jolyn Holliday Veza

Adult Health · Greenfield, INNPI 1871848770

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,902 of the $17,042 with a category attached, or 75.7%. 60 manufacturers reported payments, led by Novartis at 27.4% of the total. Among adult health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,042in general payments, 2019–2025

Across 725 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$5K
  • AstraZeneca$924
  • Exelixis Inc.$856
  • Merck$815
  • Pfizer$811
  • Johnson & Johnson$758
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$12,90276%
  • Education$7594%
  • Other$3,38120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis124$4,668
AstraZeneca(2 entities)48$924
Exelixis Inc.19$856
Merck43$815
Pfizer48$811
Johnson & Johnson30$758
Eisai Inc.33$587
Seagen Inc.22$572
Sanofi23$555
Gilead(2 entities)25$549
E.r. Squibb & Sons, L.L.C.28$500
Daiichi Sankyo Inc.21$457
AbbVie15$339
Bristol Myers Squibb18$336
Coherus Oncology, Inc.16$305
Amgen18$272
Lilly USA, LLC13$236
Genentech USA, Inc.14$229
Jazz Pharmaceuticals Inc.8$155
Genmab U.S., Inc.8$153
Adaptive Biotechnologies Corporation7$146
Sobi, Inc10$145
Servier Pharmaceuticals LLC7$140
Pharmaessentia USA Corporation8$139
Incyte Corporation8$137
Tersera Therapeutics LLC6$132
GSK8$128
Sanofi-aventis U.S. LLC2$120
Ipsen Biopharmaceuticals, Inc5$115
Regeneron Healthcare Solutions, Inc.5$112
EMD Serono, Inc.5$111
Taiho Oncology, Inc.5$110
Takeda Pharmaceuticals U.S.A., Inc.5$109
Acrotech Biopharma Inc.6$99
ADC Therapeutics America, Inc.5$93
Pharmacosmos Therapeutics Inc.4$83
Array Biopharma Inc3$78
Tempus AI, Inc3$76
Beigene USA, Inc.5$76
Astellas Pharma US Inc4$70
Pharming Healthcare, Inc.3$69
Sun Pharmaceutical Industries Inc.3$61
Rigel Pharmaceuticals, Inc.3$53
Beone Medicines USA, Inc.3$52
Pharmacyclics LLC, An Abbvie Company2$41
Tolmar, Inc.2$34
Pharmaand GmbH2$34
Boehringer Ingelheim2$34
Legend Biotech USA Inc.2$34
CTI Biopharma Corp.2$31
Morphosys, US Inc.2$30
Janssen Scientific Affairs, LLC1$26
Geron Corporation1$25
Hologic Sales And Service, LLC1$23
Mayne Pharma Commercial LLC1$21
Boston Scientific1$21
Organon1$20
Deciphera Pharmaceuticals Inc.1$19
Mirati Therapeutics, Inc.1$19
Bayer1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,042 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana

Medicare billing

Part B allowed, 2024
$30,856
Medicare patients
272
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PromactaEltrombopag Olamine13$91,649
EliquisApixaban94$73,735
XareltoRivaroxaban33$36,478
OxycontinOxycodone Hcl17$7,329
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen125$3,476
Anastrozole154$3,262
Abiraterone Acetate12$2,570
Letrozole74$1,639
Tamoxifen Citrate38$1,064
Ondansetron OdtOndansetron65$880
Oxycodone Hcl58$854
Fentanyl11$582
Dexamethasone27$574
Gabapentin31$508
Acyclovir20$468

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisPromacta$4,668$91,64913 claims
PfizerEliquis$811$73,73594 claims
Johnson & JohnsonXarelto$758$36,47833 claims
Janssen Scientific Affairs, LLCAbiraterone Acetate$26$2,57012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 391 adult health providers in Indiana.

Other adult health in Greenfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →